FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 1860504 · Received October 7, 2010

Report

Report Number
2124215-2010-14955
Event Type
Malfunction
Date Received
October 7, 2010
Date of Event
January 11, 2010
Report Date
July 23, 2010
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

AS OF TODAY, THE DEVICE REMAINS IN SERVICE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC CRM RECEIVED INFORMATION THAT THE PATIENT IMPLANTED WITH THIS DEVICE HAD A RAPIDLY CONDUCTING ATRIAL FIBRILLATION WHICH RESULTED IN INAPPROPRIATE ANTI-TACHYCARDIA PACING (ATP) TO BE DELIVERED. THE ATP ACCELERATED THE RHYTHM FOR WHICH INAPPROPRIATE SHOCKS WERE DELIVERED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E102

Patients

Seq Age Sex Outcome Treatment
1 76 YR 7000| 6947| E102| 0184